In another study, liraglutide reduced the LVPWT of rats with abdominal aortic constriction 34
Continue reading After 6 months of treatment, use of GLP-1 medications was associated with: Increased risk of androgenic alopecia Increased risk of non-scarring hair loss No significant change to the risk of telogen effluvium No significant change to the risk of alopecia areata After 12 months of treatment, use of GLP-1 medications was associated with: Increased risk of androgenic alopecia Increased risk of non-scarring hair loss Increased risk of telogen effluvium No significant change to the risk of alopecia areata Interestingly, no increased risk of alopecia areata was found, given that GLP-1 medications like semaglutide have been reported to be linked to this condition in case studies
We identified 4,691,652 patients with type 2 diabetes, among whom 231,075 initiated semaglutide and 189,103 initiated dulaglutide
This becomes more of a problem if you use a medicine that helps lower blood sugar
The medication has the same active molecule as Wegovy, a medication approved for weight loss
